Hi @wombat777, once again thanks for your R&A. I'm just trying to understand your numbers. Can you please clarify some of your assumptions for me?
-5% share of treatment
-Pricing Based on average USD $333k for midpoint 900 patients against revenue USD $300M,
Are you saying our revenue or profit is 5% of the treatment revenue shared with a partner co?
Are you assuming 900 patients as a market penetration of the 3933 new cases each year?
Many thanks
Easysell
The RAC 3-Pillar Trifecta, page-190
-
- There are more pages in this discussion • 235 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.88 |
Change
0.025(1.35%) |
Mkt cap ! $319.4M | |||
| Open | High | Low | Value | Volume |
| $1.85 | $1.89 | $1.85 | $74.38K | 39.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18943 | $1.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.88 | 199 | 1 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |